Dec 23 2009
Federal legislation on health care reform and coverage expansion will have major impacts on cancer care. Community oncology professionals need to know how this legislation impacts them and their community practice. US Oncology, Inc., supporting the nation's foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to discover how this new legislation will impact cancer care in 2010. Hosted by Matt Brow, vice president of Government Relations and Public Policy for US Oncology, the webinar will be held at 1 p.m. EST (10 a.m. PST) on Thursday, Jan. 7, 2010. To register, visit www.opspharmacist.com/opes. Registration is free, but space is limited.
Key components of the House and Senate Bills will have profound implications on community care. Brow will explain in detail the latest updates from Washington DC regarding the Congressional efforts to enact health care reform, coverage expansion legislation and what this means for community oncology practices.
"With the many changes in legislation that will directly impact cancer care physicians and patients across the country, it is imperative that practices understand these new developments and their implications to oncology," says Brow. "This interactive webinar will address questions about the new changes in government and help physicians better prepare their practices for 2010 and beyond."
US Oncology offers free webinars designed to provide community-based oncology practices with information and education to help them successfully negotiate today's cancer care environment. The company is well aligned with more than 1,300 oncologists from across the nation, is active in all relevant health care initiatives, and is pursuing legislation that supports the delivery of quality cancer care in the community. US Oncology is dedicated to providing the industry with timely and important information about current legislation changes that will impact its network and community-based oncology overall.
SOURCE US Oncology, Inc.